Hyundai Pharmaceutical Co., Ltd. (KRX:004310)

South Korea flag South Korea · Delayed Price · Currency is KRW
11,920
-890 (-6.95%)
At close: Feb 27, 2026
240.57%
Market Cap 329.92B
Revenue (ttm) 108.14B
Net Income (ttm) 1.41B
Shares Out 27.68M
EPS (ttm) 60.34
PE Ratio 197.55
Forward PE n/a
Dividend 30.00 (0.25%)
Ex-Dividend Date Mar 3, 2026
Volume 3,312,278
Average Volume 4,513,577
Open 12,800
Previous Close 12,810
Day's Range 11,710 - 12,800
52-Week Range 2,995 - 15,960
Beta 0.82
RSI 48.99
Earnings Date n/a

About Hyundai Pharmaceutical

Hyundai Pharmaceutical Co., Ltd. manufactures and distributes pharmaceutical products, health food drinks, and medical devices in South Korea and internationally. The company offers a range of ETC and OTC products in various therapeutic areas, including antianginal, antibiotic, antiemetics+antinauseants, antihistamines and antiallergics, antihyperlipidemic, antihypertensive, antiplatelet agent, antitussives, cell stimulants and proliferants, central nervous system, depilatory, dermatological agent, dermatology, dietary supplements, digestive sy... [Read more]

Sector Healthcare
Founded 1965
Employees 393
Stock Exchange Korea Stock Exchange
Ticker Symbol 004310
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.